Home About Contact Add Activities Provider Login

i3 Health

	Applying Precision Medicine in BRAF V600E–Mutant Metastatic Colorectal Cancer STATEMENT OF NEED Colorectal cancer is the second leading cause of cancer death among men and women in the United States (ACS,2021). An estimated 149,500 new cases are diagnosed annually, and 52,980 people die of the disease (ACS, 2021). When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because colorectal cancer initially exhibits no symptoms and ... i3 Health
	Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy CIPN is a complication of cancer treatment that may lead to permanent nerve damage in severe cases. This online activity reviews causative agents, signs and symptoms, and supportive care interventions. 1.0 NCPD \| ILNA STATEMENT OF NEED Chemotherapy-induced peripheral neuropathy (CIPN) is a complication of cancer treatment that may impair quality of life and lead to treatment dose reductio... i3 Health
	Best Practices in the Management of Tumor Lysis Syndrome Associated With Emerging Cancer Therapies Explore best practices in the management of tumor lysis syndrome associated with emerging cancer therapies. This activity, presented by Matthew S. Davids, MD, MMSc, Director of Clinical Research at Dana-Farber Cancer Institute, and Amy Goodrich, RN, BSN, MSN, CRNP-AC, Nurse Practitioner at Johns Hopkins Kimmel Cancer Center, will review plans to optimize prevention, recognition, and treatment, a... i3 Health
	Burnout-Prevention and Coping Tactics for Oncologists This episode of Oncology Data Advisor with Daniel McFarland, DO, Northwell Health Lenox Hill Hospital, focuses on physician burnout, work-related stress, and the effects, including depression and exhaustion, that many physicians are facing from the challenges of the COVID-19 pandemic. Listen now to learn new strategies to combat these challenges! STATEMENT OF NEED Physician burnout and wor... i3 Health
	Emerging Treatment Strategies for Advanced Cholangiocarcinoma This in-depth discussion, presented by Lipika Goyle, MD, Massachusetts General Hospital, will feature expert insights on emerging therapeutic treatments, recent discoveries on novel therapies, managing strategies for monitoring and managing adverse events, and much more! Start the activity now! STATEMENT OF NEED Cholangiocarcinoma, also known as bile duct cancer, is a rare malignancy origi... i3 Health
	Enhancing the Clinical Outcomes of Patients with Extensive–Stage Small Cell Lung Cancer Anne Chiang, MD, PhD, Yale School of Medicine, a leading expert on small cell lung cancer, for an in-depth presentation on patient outcomes in extensive-small cell lung cancer. Dr. Chiang will present evidence-based advice regarding emerging therapies, strategies for targeted treatments and immunotherapy, optimization of individual patient treatment plans, managing adverse events, and much more!... i3 Health
	Management of Cancer Pain: Current Guidelines STATEMENT OF NEED Patients with cancer often suffer from a range of symptoms that negatively impact their quality of life. Among the most significant of these symptoms is pain, which can be caused by surgery, radiation, chemotherapy, targeted therapy, diagnostic procedures, and/or supportive care measures. Between 20% and 50% of patients with cancer experience pain, including moderate-to-seve... i3 Health
	Metastatic Breast Cancer: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care STATEMENT OF NEED Breast cancer accounts for approximately 30% of cancer diagnoses among women in the United States and is the second-leading cause of cancer death in this population (ACS, 2019). Although many women benefit from regular screening as well as earlier and improved treatment, approximately 6% present with metastatic disease, and up to 30% with no initial lymph node involvement ev... i3 Health
	Metastatic Triple-Negative Breast Cancer: Applying Treatment Advances to Personalized Care Sara A. Hurvitz, MD, FACP, Director of the Breast Cancer Clinical Trials Program at the David Geffen School of Medicine at UCLA, and a prominent authority on TNBC, provides perspectives on personalized care plans for patients with metastatic TNBC, efficacy and safety of emerging treatments, strategies to improve quality of life for patients with metastatic TNBC, and much more! Start the activit... i3 Health
	New Data and Clinical Perspectives on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer STATEMENT OF NEED Prostate cancer is the most common tumor type affecting men in the United States. An estimated 191,930 new cases are diagnosed annually, and 33,330 people die from the disease (ACS, 2020). Most patients with metastatic hormone-sensitive prostate cancer (HSPC) present with relapse after local treatment, while approximately 5% of all prostate cancer patients present with de no... i3 Health
	New Data and Emerging Management Strategies for Migraine Headache STATEMENT OF NEED Migraine is a type of chronic headache disorder characterized by headaches of a stabbing, pulsatile quality that last between 4 and 72 hours each, often accompanied by symptoms of nausea and sensitivity to light and noise. An estimated 1.04 billion individuals have been diagnosed with migraine worldwide (Negro et al, 2019). Patients report that migraine impacts virtually eve... i3 Health
	New Opportunities in Advanced KRAS Mutation-Positive NSCLC In this CME/NCPD activity, D. Ross Camidge, MD, PhD, of the University of Colorado, and Beth Sandy, MSN, CRNP, OCN®, of the University of Pennsylvania, discuss novel treatments for advanced KRAS mutation-positive NSCLC and how to manage adverse events associated with small molecule inhibitors. Start now! An estimated 228,820 new cases of lung cancer are reported in the United States annua... i3 Health
	New Perspectives on Diagnosis and Treatment of EGFR Exon 20 Insertion–NSCLC Discover new developments in the diagnosis and treatment of EGFR exon-20 Insertion–Mutant NSCLC and assess emerging efficacy and safety data on novel targeted therapies. This activity features expert insights from Helena Yu, MD, Memorial Sloan Kettering Cancer Center, and Maria Arcila, MD, Memorial Sloan Kettering Cancer Center. This activity is also available as a podcast. An estimated... i3 Health
	Nursing Management of Bone Health in Patients With Cancer STATEMENT OF NEED Many tumors, such as prostate, breast, lung, and multiple myeloma, affect bone health. Once cancer spreads to the skeletal system, the risk for pain, fractures, hypercalcemia, and nerve compression increases considerably. Several studies have shown that the use of antiresorptive agents such as bisphosphonates and monoclonal antibodies can reduce the morbidity of skeletal com... i3 Health
	Nursing Management of Oral Mucositis Oral mucositis is considered one of the most debilitating side effects of cancer therapy. This online activity reviews pathobiology, risk factors, clinical assessment, and supportive care interventions. STATEMENT OF NEED Oral mucositis (OM) is the inflammation of oral mucosa resulting from cancer therapy and manifesting as atrophy, swelling, erythema, and ulceration (Oronsky et al, 2018). ... i3 Health
	Nursing Management of Venous Thromboembolism in Ambulatory Patients With Cancer VTE is a common and potentially life-threatening complication in patients with cancer. This online activity reviews VTE pathophysiology, risk assessment, and supportive care interventions for ambulatory cancer patients. Venous thromboembolism (VTE) is a common and potentially life-threatening complication in patients with cancer. There are two main types of VTE: deep vein thrombosis (DVT) and... i3 Health
	Nursing Management of Venous Thromboembolism in Hospitalized Patients With Cancer VTE is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold increase in likelihood of death. This online activity reviews signs and symptoms, risk assessment, and supportive care interventions. STATEMENT OF NEED Venous thromboembolism (VTE), which consists primarily of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a life-t... i3 Health
	Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 1 - Diffuse Large B-Cell Lymphoma In the first segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD Anderson Cancer Center, evaluates guideline recommendations for the management of patients with advanced diffuse large B-cell lymphoma (DLBCL). Learners will receive expert insight on assessing emerging data on novel therapies, strategies to manage adverse events, and optimizing tr... i3 Health
	Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 2 - Mantel Cell Lymphoma In the second segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD Anderson Cancer Center, shares expert insights on guideline recommendations for optimizing individual patient care, efficacy and safety data, and strategies to manage adverse event for patients with advanced aggressive mantle cell lymphoma (MCL). For more expert insights on aggressiv... i3 Health
	Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 3 - Peripheral T-Cell Lymphoma In the third segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD, Anderson Cancer Center, evaluates guideline recommendations for the management of peripheral T-cell lymphoma (PTCL), assesses emerging data on novel therapies, and applies strategies to optimize treatment experiences for patients. For more expert insights on aggressive non-hodgkin l... i3 Health
	Optimizing the Management of Moderate-to-Severe Atopic Dermatitis in Adult Patients STATEMENT OF NEED Atopic dermatitis is a severe form of eczema pathologically characterized by skin barrier disruption mediated by a type 2 helper T-cell immune response. The incidence of atopic dermatitis is high, estimated to be approximately 15% to 20% in children and 1% to 3% in adults worldwide (Avena-Woods, 2017). In addition to the hallmark clinical symptoms of eczema and intense pruri... i3 Health
	Optimizing Treatment Sequencing for Patients With Relapsed/ Refractory Multiple Myeloma Discover new developments in sequential treatment and clinical findings, evaluate strategies to manage and monitor adverse events, and initiating therapy for patients with relapsed/refractory Multiple Myeloma, and much more! Leading oncologist Shaji Kumar, Mayo Clinic Cancer Center, presents this in-depth discussion. Start the activity now! STATEMENT OF NEED Multiple myeloma (MM) is a B-c... i3 Health
	Podcast: Applying Precision Medicine in BRAF V600E–Mutant Metastatic Colorectal Cancer STATEMENT OF NEED Colorectal cancer is the second leading cause of cancer death among men and women in the United States (ACS,2021). An estimated 149,500 new cases are diagnosed annually, and 52,980 people die of the disease (ACS, 2021). When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because colorectal cancer initially exhibits no symptoms and ... i3 Health
	Podcast: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced ... i3 Health
	Podcast: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer In this episode of Oncology Data Advisor TM, learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and... i3 Health
	Prevention of Medical Errors in Nursing Practice Medical errors are among the most common health-threatening mistakes that affect patient care. This online activity reviews the categories of medication errors, at-risk patient populations, and best practices in error analysis and reporting. STATEMENT OF NEED Medical errors are among the most common health-threatening mistakes that affect patient care, accounting for as many as 250,000 dea... i3 Health
	Understanding Evolving Therapeutic Strategies for Graft-Versus-Host Disease (Module 1: Diagnosis, Risk Assessment, and Staging; Module 2: Current and Emerging Therapeutic Strategies) STATEMENT OF NEED Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (HSCT), affecting between 40% and 60% of patients and accounting for 15% of posttransplant mortality. Acute GVHD is the second-leading cause of transplant-related mortality and typically targets the skin, gastrointestinal tract, and liver. Chronic GVHD often presents dur... i3 Health
	Update on Immunotherapeutic Strategies for Advanced Merkel Cell Carcinoma STATEMENT OF NEED Merkel cell carcinoma is a rare and aggressive neuroendocrine tumor of unknown origin that typically presents in older white and immunocompromised adults. An estimated 2,488 cases are diagnosed in the United States annually (Paulson et al, 2018). The incidence of MCC has risen rapidly during the past few decades, which has been attributed in part to people living longer with... i3 Health
	Update on Therapeutic Advances in T-Cell Lymphoma Join Steven M. Horwitz, MD, Member and Attending Physician at Memorial Sloan Kettering Cancer Center, as he discusses guideline recommendations for differential diagnosis of TCL, novel treatment strategies, and best practices for managing side effects in this case-based CME/NCPD activity! STATEMENT OF NEED Each year, 74,240 new cases of non-Hodgkin lymphoma are diagnosed and 19,940 people... i3 Health
	Video Viewpoint Strategy Session: Advances in the Treatment of Relapsed/Refractory Immune Thrombocytopenia Learn new advances in the treatment of relapsed or refractory immune thrombocytopenia, including treatment differentiation, efficacy and safety strategies, and much more. This activity features perspectives from two noted experts in the field, Dr. Keith McCrae, Director of Benign Hematology at the Cleveland Clinic Taussig Cancer Center; and Ms. Phyllis McKiernan, Advanced Practice Nurse in Blood... i3 Health
	Video Viewpoint Strategy Session: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced ... i3 Health
	Video Viewpoint Strategy Session: Optimizing Treatment and Functional Outcomes in Head and Neck Squamous Cell Carcinoma Gain expert insight on emerging treatment approaches for patients with head and neck squamous cell carcinoma, incuding the safety and tolerabilty of emerging treatments, survivorship care, and much more. This activity is presented by leading experts, Barbara Burtness, MD, Professor of Medicine at Yale School of Medicine and Smilow Cancer Hospital, and Lynsey Teulings, NP, Nurse Practitioner at Y... i3 Health
	Video ViewPoint Strategy Session: Rethinking the Management of Differentiated and Anaplastic Thyroid Cancers Gain expert insight and strategies for the management of anaplastic thyroid cancer including emerging data on immunotherapies, and treatment to manage adverse events. This activity is presented by leading experts, Jochen Lorch, MD, MSc, Director Thyroid Cancer Center, Dana-Farber Cancer Institute, and Carolyn Grande, CRNP, AOCNP®, Oncology Nurse Practitioner, Abramson Cancer Center. STATEMEN... i3 Health
	Video Viewpoint Strategy Session: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer Learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts G... i3 Health

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map